-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Pharma-Bio Serv, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2010 to 2024.
- Pharma-Bio Serv, Inc. Income Tax Expense (Benefit) for the quarter ending January 31, 2025 was $1.12K, a 91.4% decline year-over-year.
- Pharma-Bio Serv, Inc. Income Tax Expense (Benefit) for the twelve months ending January 31, 2025 was $10.3K, a 95.7% decline year-over-year.
- Pharma-Bio Serv, Inc. annual Income Tax Expense (Benefit) for 2024 was $22.2K, a 94.1% decline from 2023.
- Pharma-Bio Serv, Inc. annual Income Tax Expense (Benefit) for 2023 was $377K, a 108% increase from 2022.
- Pharma-Bio Serv, Inc. annual Income Tax Expense (Benefit) for 2022 was $182K, a 14.8% decline from 2021.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)